Cidara Therapeutics to Participate in World Health Organization Meeting on H5N1 Influenza Preparedness and Response
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced participation in the ...
Golf Digest on MSN55m
Valspar Championship picks 2025: Can we go for three in a row?
After hitting on Russell Henley at Bay Hill and Rory McIlroy at TPC Sawgrass, our panel looks to stay hot at Innisbrook.
Velo3D Introduces New Rapid Production Solutions - Significantly Expands Addressable Market to Meet Growing Demand for High-Quality Production Parts
Velo3D, Inc. (OTC: VLDX) - a leader in additive manufacturing (AM) technology known for transforming aerospace and defense supply chains through world-class metal AM, is proud to unveil its latest ...
Acrivon Therapeutics to Host Corporate R&D Event to Provide AP3 Platform Capabilities and Clinical ACR-368 and ACR-2316 Program Updates
Event to be held via webcast on March 25, 2025 at 4:00 p.m. ETTo highlight differentiated drug discovery capabilities with its Generative ...